Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to March 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $4.6B |
| Sales growthchange from the year before | +2.7% |
| Operating marginshare of sales left after running the business | 2.3% |
| Net marginshare of sales kept as profit | -0.7% |
| Return on invested capitalprofit made on each $100 put into the business | 1.9% |
| Return on equityprofit vs. shareholders' accounting value | -0.7% |
| Interest coverhow many times profit covers interest payments | 0.3x |
| Change in share countnegative = the company is buying back its shares | +4.9% |
3 insiders sold $517K (all under pre-arranged plans) on the open market.
| Stenbit John PDirector | Sold (plan)Aug 3 | 616 shat $75.46 · $46K |
| Palmer Benjamin EdwardSVP, Pres Commercial | Sold (plan)Aug 3 | 2,400 shat $75.46 · $181K |
| Chase Garrett L.SVP, Chief Financial Officer | Sold (plan)Jul 20 | 4,000 shat $72.23 · $289K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy